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Summary
A 4-year old male Australian Cattle Dog involved in a 
road traffic accident was presented with severe polytrau-
ma to the Small Animal Clinic, University of Zurich. 
He was presented in hemorrhagic shock, with an initial 
lactate of 10.3mmol/l and ongoing bleeding from mul-
tiple injury sites. Acute traumatic coagulopathy diag-
nosed with ROTEM within one hour after accident 
showed marked hypocoagulation and hyperfibrinolysis. 
Treatment with a total dose of 40mg/kg of tranexamic 
acid intravenously resulted in successful elimination of 
hyperfibrinolysis in the following, serially measured 
ROTEM tracings.
Keywords: canine, ATC, trauma, fibrinolysis, ROTEM
Diagnose von Hyperfibrinolyse mit-
tels Rotations-Thromboelastometrie 
und Behandlung mit Tranexamsäure 
bei einem Hund mit akuter trauma-
tischer Koagulopathie
Ein 4-jähriger, männlicher Australian Cattle Dog wurde 
mit schwerem Polytrauma nach einem Verkehrsunfall 
an der Kleitierklinik der Universität Zürich vorgestellt. 
Er war in hämorrhagischem Schock, hatte mehrere blu-
tende Wunden und ein Laktat von 10.3mmol/l bei Ein-
tritt. Die akute Traumatische Koagulopathie (ATC) 
wurde mittels Rotationeller Thromboelastometrie 
 (ROTEM) diagnostiziert und zeigte sich in markanter 
Hypokoagulabilität und Hyperfibrinolyse. Die Behand-
lung mit insgesamt 40mg/kg Tranexamsäure i.v. resul-
tierte in einer erfolgreichen Therapie der Hyperfibri-
nolyse in den folgenden, seriell gemessenen ROTEM 
Untersuchungen.
Schlüsselwörter: Hund, ATC, Trauma, Fibrinolyse, ROTEM
Introduction 
Acute traumatic coagulopathy (ATC) describes a sys-
temic coagulopathy following trauma. It is thought to 
result from tissue injury in combination with hypoper-
fusion and systemic inflammation, followed by a dy-
namic and complex process. Hypothermia, acidosis and 
hemodilution further impair the initiated coagulopathy 
(Brohi, et al., 2007; Frith, et al., 2010; Cohen, et al., 
2013; Davenport, et al., 2016;). ATC can be character-
ized by hypercoagulation, hypocoagulation and hyper-
fibrinolysis, varying with increased injury severity and 
depending on time after injury (Dobson, et al., 2015). 
ATC occurs in up to 30% of the severely injured human 
trauma patients and increases mortality at least fourfold 
(Brohi, et al., 2003; Maegele, et al., 2007; Frith, et al., 
2010). 
The diagnosis of ATC remains controversial, as there is 
no standardized and globally established test in human 
or veterinary medicine. Traditional coagulation tests like 
activated partial thromboplastin time (aPTT) and pro-
thrombin time (PT) have been used along with platelet 
count and serum fibrinogen measurements to diagnose 
ATC (Cohen, et al., 2013). Viscoelastic tests such as 
rotational thromboelastometry (ROTEM) or thromboe-
lastography (TEG) may be superior to assess coagulation 
in ATC, as they not only assess plasmatic coagulation, 
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Case History
Physical examination
A 4-year old, male Australian cattle dog was presented 
to the emergency service of the Small Animal Clinic 
University of Zurich within fifteen minutes after being 
hit by bus. The dog was severely injured (Animal trauma 
triage score 13/18 (Rockar and 1994)) and presented in 
lateral recumbency. At presentation, the dog showed 
pale mucus membranes, a capillary refill time (CRT) of 
3 seconds, a weak femoral pulse, a heart rate of 200 bpm 
and a rectal temperature of 39.2 °C. Respiratory rate 
(RR) was 24/min, with regular thoracic movements and 
unremarkable lung auscultation. There was a large area 
of anatomical degloving of the left abdominal wall, a 
ventral abdominal wall defect with evisceration of in-
testinal loops, a traumatic prepubic hernia with viola-
tion of the right vascular lacuna and laceration of the 
femoral artery and vein with active bleeding. Multiple, 
severe soft tissue lesions with muscular tear and diffuse 
bleeding of adductor muscles of the right thigh were 
noted. 
Therapy
Oxygen was supplemented by face mask, a peripheral 
venous catheter was inserted and a stat acid-base analy-
sis (RAPIDPoint 500, Siemens Schweiz AG) was per-
formed. The dog received 4ml/kg of 7.2% NaCl (Natri-
umchlorid „Bichsel“ 7.2%, Dr. G. Bichsel AG, 3800 
Interlaken), 10ml/kg of Ringer’s acetate (Ringer-Acetat 
Fresenius i.v., Fresenius Kabi, 6370 Oberdorf ) and 
5ml/kg of hydroxyethyl starch (Voluven 6% balanced 
i.v., Fresenius Kabi, 6370 Oberdorf ) as boluses over ap-
proximately five minutes each. The first detectable 
blood pressure during fluid resuscitation was 40mmHg 
measured by Doppler. The dog further received 20mg/kg 
of tranexamic acid (Cyclokapron®, Pfizer Corporation 
Austria, 1210 Wien), 0.2mg/kg of methadone (Metha-
but also the formation and strength of the formed clot 
and its lysis (Frith, et al., 2010; Davenport, et al., 2011; 
Hagemo, et al., 2015; Rossaint, et al., 2016). 
The ROTEM device (ROTEM delta, Pentapharm 
GmbH D-81829 München) measures the viscoelastic 
properties of whole blood under low shear conditions. 
The changes in viscoelasticity are visualized in a tracing 
and several parameters are automatically determined. 
The clotting time (CT) describes the time until fibrin 
formation starts and is comparable to PT and aPTT. The 
clot formation time (CFT) is determined by the kinetics 
of clot formation and depends mainly on fibrinogen 
concentration and thrombocytes numbers. The maxi-
mum clot firmness (MCF) describes the maximal 
strength of the fibrin/thrombocytes clot. Fibrinolysis 
can be assessed with the maximum lysis (ML). Several 
coagulation activators can be used. The ExTEM test 
measures clot formation by activation of the coagulation 
cascade through proprietary tissue factor (extrinsic path-
way) while the InTEM uses phospholipids and ellagic 
acid and activates coagulation via intrinsic pathway.  In 
the ApTEM test, fibrinolysis is inhibited by added apro-
tinin, an antifibrinolytic, to the ExTEM reagent. The 
FibTEM tracing enables determination of fibrinogen by 
added cytochalasin D, a platelet inhibitor, to the ExTEM 
reagent (Spiel, et al., 2006). 
In veterinary medicine there are only a few studies in-
vestigating ATC in canine trauma patients (Mischke, 
2005; Abelson, et al., 2013; Holowaychuck, et al., 2014; 
Gottlieb, et al., 2016;) and most information regarding 
diagnosis and pathophysiology is derived from human 
medicine. To our knowledge, hyperfibrinolysis identi-
fied with ROTEM has not yet been described in canine 
trauma patients. 
Figure 1: ExTEM (1a) and ApTEM (1b) profile of a dog with acute traumatic coagulopathy after initial therapy.  Both profiles 
show hypocoaguability with a maximum clot firmness of 40 mm in ExTEM. The ExTEM profile shows hyperfibrinolysis, 
starting after 30 minutes. Lysis cannot be seen in the ApTEM, suggesting the identified lysis in the ExTEM profile represents 
true hyperfibrinolysis (Ganter, 2008)
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don Streuli®, Streuli Pharma AG, 8730 Uznach) and 
20mg/kg of ampicillin-sulbactam (Ampicillin/Sulbac-
tam 1000mg/500mg, Aurobindo Pharma GmbH, 81829 
München). After this initial therapy, another blood 
sample was analyzed. Initial blood results are listed in 
Table 1.
Thromboelastometry
ROTEM analysis showed decreased clot strength and 
prolonged clotting time (Tab. 2). In the ExTEM tracing, 
hyperfibrinolysis with ML of 41% (reference interval 
0-10%) was detected. The ApTEM tracing showed a ML 
of 1% (reference interval 0-3%), confirming hyperfi-
brinolysis (Fig. 1). Fibtem MCF was 4mm (reference 
interval: 3-9mm). Based on these findings, tranexamic 
acid (20mg/kg) was repeated one hour after the first 
dose. 
The dog was further stabilized and the right A. /V. fem-
oralis were cross clamped with haemostats and ligated 
to control the ongoing bleeding. The eviscerated intes-
tines and wounds were covered with sterile moist ab-
dominal sponges.
Table 2: Different ROTEM Tracings (ExTEM, ApTEM, FibTEM) after 0:15h, 9:40h, 24h and 48h.
EXTEM APTEM FIBTEM
Parameter A5 
[mm]
CT 
[sec]
CFT 
[sec]
MCF 
[mm]
ML 
[%]
CT 
[sec]
CFT 
[sec]
MCF 
[mm]
ML 
[%]
CT 
[sec]
MCF 
[mm]
Reference  
interval*
N/A 26-57 53-153 46-62 0-10 31-59 67-164 52-65 0-3 35-108 3-9
0:15h 23 111 229 40 41 65 285 43 1 163 4
9:40h 25 47 210 48 1 54 228 46 1 154 5
24h 26 47 210 51 0 55 237 48 1 61 5
48h 135 4
*  in-house references 
A5: Amplitude 5min after CT; CT: Clotting Time; CFT: Clot Formation Time; MCF: Maximum Clot Firmness; ML: Maximum 
Lysis
Table 1: Blood Values (Blood gas, CBC and clinical Chemistry) at different time points during hospital stay.
Time after admission [h:min] 0:0 0:15 03:06* 9:40 15:00** 24:00 48:00
Reference 
interval
Blood Gas 
[V: venous; A:arterial] V V V V V V A A
pH 7,35-7,45 7,21 7,21 7,28 7,37 7,31 7,34 7,25
pCO2 [mmHg] 29-43 29,4 32,4 41,6 40,1 39,1 33,5 25,8
pO2 [mmHg] 30-53 72,4 135,8 58,3 54,1 33,9 100,2 95,7
HCO3 - std [mmol/l] 20-25 13,9 13,6 18,5 22,4 18,8 18,4 13
BE(B) [mmol/l] -7 - 2 -14,5 -14 -7,1 -2,3 -6,2 -7,3 -14,6
Hct [%] 35-61 60 33 40 N/A 23 21 28
K+ [mmol/l] 3,6-4,7 3,97 3,84 4,49 4,52 4,37 3,46 3,60
Ca++ [mmol/l] 1,21-1,41 1,23 1,03 1,09 1,45 1,21 1,23 1,24
Glu [mmol/l] 3,9-6,6 15 10,6 13,1 5,3 6,7 6,7 6,4
Lac [mmol/l] 0,42-2,13 10,36 6,53 3,35 2,61 1,48 1,18 2,94
CBC
Hct [%] 42-55 30 29 19
Leukocytes *10E3/ul 4,7-11,3 3,2 6,2 0,6
Thrombocytes *10E3/ul 108 64
Clinical Chemistry
Alb g/l 29-37 12 6 21 20 14
**  Whole Blood Transfusion at 1:30h (22ml/kg); Surgery from approximately 3:00 to 8:30h;
**  20% Human Serum Albumin Transfusion (1g/kg) at 10:30h. 
BE (B): Base Excess of Blood; Hct: Hematocrit; Glu: Dextrose; Lac: Lactate; Alb: Albumin; N/A: not available. CBC: Complete 
Blood Count, performed automatically on a Sysmex  XT  2000i  (Sysmex  digitana, CH-Horgen). Clinical Chemistry was 
performed on a Cobas 6000 (Cobas 6000. Roche Diagnostics AG, CH-Rotkreuz)
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Diagnostic imaging and surgery
Fifty minutes after admission a whole body CT study 
was performed. The CT revealed multiple pelvic frac-
tures, right fibula and tibia fractures, complete musculus 
rectus abdominis avulsion, free abdominal gas, but no 
detectable lesion of the skull, spine or thorax. 
After receiving a unit of matched fresh whole blood 
(22 ml/kg), anaesthesia was co-induced with ketamin 
5mg/kg (Ketanarkon 100, Streuli Pharma AG, 8730 
Uznach) and midazolam 0.25mg/kg (Dormicum®, 
 Roche Pharma (Schweiz) AG, 4153 Reinach) and main-
tained with sevoflurane in air/oxygen (1:1). Intra-oper-
ative analgesia was provided by lidocain (1.8 mg/kg/h) 
(Lidocain HCl „Bichsel“ 2%, Dr. G Bichsel AG, 3800 
Interlaken), fentanyl (0,25ug/kg/h) (Fentanyl Sintetica, 
Sintetica AG, CH-6850 Mendrisio) and ketamin (0.6mg/
kg/h). During the anaesthesia of about 8 hours, the dog 
was cardiovascularly stable with a mean arterial blood 
pressure (MAP) of >70mmHg throughout anaesthesia. 
Despite active warming following induction, rectal body 
temperature dropped to 34.4 °C during anaesthesia. 
During and after surgery, follow-up arterial blood gas 
analyses (Tab. 1) were performed and electrolyte abnor-
malities were corrected. Exploration of the abdomen 
was performed. The eviscerated intestinal bundle was 
copiously rinsed with warm Ringer’s acetate before 
transferred back in the abdominal cavity. Resection and 
anastomosis of approximately 70cm of mid jejunum was 
performed due to avulsion of mesentery and associated 
vasculature and a partial omentectomy was performed. 
The complete avulsion of the tendo prepubicus was fixed 
to the pelvis with four drill holes and non-absorbable 
suture size 1 (Prolene®, Ethicon, Somerville, NJ 08876). 
The inguinal wound was lavaged and the right A./V. 
femoralis was sealed proximal to the ligation with an 
electrothermal bipolar tissue sealing system (LigaSure®, 
Covidien Medtronic plc, Dublin Ireland). The adductor 
muscles were debrided and repositioned and three active 
drains (Blake®, Ethicon, Somerville NJ 08876) were 
placed.. Following closure of the abdomen, a vacuum 
assisted closure system (V.A.C®, KCI medical, San An-
tonio, TX 78265) was placed on the degloving defect on 
the flank. Intraoperatively, the bleeding from major 
vessels was controlled and diffuse bleeding from the 
peritoneal surface was noted.
Postoperative care
Approximately 10 hours after admission the dog was 
transferred to the intensive care unit, where another 
blood sample was taken from the indwelling central 
venous catheter for ROTEM analysis and determination 
of serum albumin concentration. At this time, the pa-
tient had received a total of 40mg/kg of tranexamic acid, 
22ml/kg of whole fresh blood, 98ml/kg of crystalloids 
(Ringer’s acetate) and 24ml/kg colloids (Voluven). The 
FibTEM and ExTEM tracings were, except for the CFT 
and Alpha Angle of the ExTEM, within normal limits 
(Tab. 2). Hematocrit was 29% (reference interval 42-
55%) and serum albumin concentration was 6g/l (refer-
ence interval 29-37 g/l). Subsequently, the dog was 
transfused with 1g/kg 20% human serum albumin (Al-
bumin CSL 20%, CSL Behring AG, 3014 Bern), which 
increased serum albumin concentration to 21g/l. The 
dog additionally received paracetamol (10mg/kg, q8h) 
(Paracetamol Fresenius, Fresenius Kabi, 6370 Oberdorf ) 
as an analgesic.
During the following 12 hours, the dog was cardiovas-
cularly stable.  The diffuse bleeding from the inguinal 
space diminished clinically approximately one hour 
after surgical intervention and administration of 
40mg/kg of tranexamic acid and no further clinical 
signs of bleeding were identified. 24h after admission 
another ROTEM analysis was performed (Tab. 2). Fol-
lowing ROTEM analysis, tranexamic acid was given one 
more time and was then discontinued, as hyperfibrinol-
ysis was not detected anymore. The dog received 
10ml/kg of cross matched concentrated red blood cells, 
increasing the hematocrit from 19% to 38%. 48h after 
admission, a CBC showed severe leucopenia and left 
shift (Tab. 1). The dog developed hypoglycaemia, MAP 
dropped to <60 mmHg and did not react to repeated 
fluid boluses with Ringer’s acetate (total of 60ml/kg) 
and Voluven (3ml/kg). Cytological evaluation of ab-
dominal fluid confirmed a septic abdomen with extra- 
and intracellular bacteria. At this time point, the owner 
elected for euthanasia. No post-mortem analysis was 
performed.
Discussion
Acute traumatic coagulopathy is a complication of trau-
ma leading to coagulopathy and clinical bleeding diath-
esis followed by increased transfusion requirement and 
increased mortality (MacLeod, et al., 2003; Brohi, et al., 
2003; Maegele, et al., 2007; Frith, et al., 2010; Daven-
port, et al., 2011). The coagulopathy is characterized by 
tissue damage through trauma and concurrent hypop-
erfusion, leading to a complex and dynamic activation 
and inhibition of several steps of haemostasis (Dobson, 
et al., 2015; Davenport and Brohi, 2016).
Hyperfibrinolysis is a common finding in people with 
severe trauma (Raza, et al., 2013; Cardenas, et al., 2014). 
The polytraumatised dog in our study showed marked 
hyperfibrinolysis which was identified by an increased 
ML starting 30 minutes after activation of the ExTEM 
tracing. Hyperfibrinolysis seen in the ExTEM tracing of 
our dog is supported by concurrent evaluation of the 
ApTEM profile, which did not show hyperfibrinolysis. 
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we cannot exclude a dilutional or hypocoaguable effect 
seen with colloids and hypertonic saline. However, dos-
es were lower than those administered in studies that 
showed significant effect on ROTEM parameters com-
pared to dilution alone (Adamik, et al., 2015; Reuteler 
et al., 2017). As described above, tissue trauma in com-
bination with hypoperfusion are the main causes for 
developing ATC. Rising injury severity is associated 
with the severity of hypocoagulation and hyperfibrinol-
ysis (Brohi, et al., 2008; Frith, et al., 2010). In a study 
with 40 dogs (Holowaychuck, et al., 2014), the finding 
of ATC, defined as two or more abnormal coagulation 
tests, was more common in dogs with higher injury se-
verity. The presented dog was severely polytraumatised, 
with an ATT score of 13/18 (Rockar, et al., 1994), and 
also severely hypoperfused at presentation, with a serum 
lactate of 10.3mmol/l and clinical signs of hypovolae-
mic shock in addition to a non measurable blood pres-
sure. In addition to tissue trauma and hypoperfusion 
leading to development of ACT, several factors are 
known to contribute to the coagulopathy: acidosis, hy-
pothermia and hemodilution. Mild acidosis was present 
at admission with a pH of 7.21, which might have had 
a worsening effect on coagulation measured by ROTEM 
(Engstrom, et al., 2006; Dirkmann, et al., 2008) and, as 
discussed above, the dog received fluid therapy prior to 
determination of ROTEM parameters. Hypothermia 
however was not present. Unfortunately, the dog did not 
survive to discharge. However, the dog was euthanized 
due to development of a septic abdomen 48 hours after 
presentation and not due to apparent signs of coagulop-
athy. 
In humans, the incidence of ATC is more than 25% in 
severely injured trauma patients (Brohi, et al., 2003; 
Maegele, et al., 2007; Frith, et al., 2010). Studies evalu-
ating ATC in dogs are limited, with a single study de-
scribing ATC in 15% of 40 dogs with severe trauma 
(Holowaychuck, et al., 2014), whereas another study of 
30 dogs with acute trauma did not find any signs of 
hypocoagulopathy at all (Abelson, et al., 2013). The 
most recent study described ATC in only one out of 
18 dogs sustaining blunt force trauma (Gottlieb, et al., 
2017). However, the incidence and outcome of ATC 
depends on how ATC is defined. In human medicine, 
several definitions of ATC exist (Brohi, et al., 2007; 
Frith, et al., 2010; Cohen, et al., 2013;Gonzalez, et al., 
2016). Previous studies evaluating ATC in dogs have 
used different definitions, since there is no formal defi-
nition. Palmer suggested that every dog who sustained 
severe trauma with the presence of severe hypoperfusion 
(MAP < 60mmHg, Base Excess < - 6mmol/l, Lactate 
> 5 mmol/l), haemorrhagic shock with uncontrollable 
bleeding and viscoelastic tracing displaying decreased 
clot strength (<40% of mean reference value) or pro-
longed traditional coagulation assays (>1.5 the labora-
The comparison of the ApTEM to the ExTEM profile 
allows the diagnosis of hyperfibrinolysis in bleeding 
human patients, as lysis is inhibited in the ApTEM re-
agent by the addition of aprotinin, an antifibrinolytic 
(Ganter, 2008). To our knowledge, this is the first de-
scription of trauma-induced hyperfibrinolysis 
in a native blood sample and proven by concurrent 
ApTEM analysis. A previous case report suspected trau-
ma-induced hyperfibrinolysis in frozen plasma samples 
that were activated with tissue plasminogen activator 
(Yoo, et al., 2016).
Hyperfibrinolysis is also not commonly identified in 
dogs with other diseases. It has been described in dogs 
with spontaneous (non-traumatic) haemoperitoneum 
(Fletcher, et al., 2015) and in dogs with Angiostrongylus 
vasorum infection (Sigrist, et al., 2017). The treatment 
of choice for hyperfibrinolysis is an antifibrinolytic 
drug, such as tranexamic acid (CRASH-2 trial collabo-
rators, 2010). The presented dog initially received 
20 mg/kg of tranexamic acid IV. The dose of tranexam-
ic acid was empirically deduced from human data and 
own clinical experience. To our knowledge, no pharma-
cological evaluation of the minimal required dose to 
inhibit hyperfibrinolysis in dogs has been performed. 
As hyperfibrinolysis was still present on the first 
 ROTEM analysis, despite administration of 20 mg/kg 
tranexamic acid five to ten minutes prior to blood sam-
pling, we suspected that the patient needed more than 
20mg/kg. While we cannot exclude that the maximal 
drug effect was not reached after 10 minutes, the finding 
of the need of higher dosages of tranexamic acid in dogs 
with overt hyperfibrinolysis and clinical signs of bleed-
ing diathesis is in accordance with findings in dogs with 
hyperfibrinolysis for other reasons (Sigrist, et al., 2017). 
Potentially, the identified hyperfibrinolysis of this dog 
may have been even more significant prior to tranexam-
ic acid administration. Hyperfibrinolysis was no longer 
detectable on ROTEM tracings after the second dose of 
tranexamic acid, however, no ROTEM analysis was 
available immediately after the second dose of tranexam-
ic acid and prior to whole blood transfusion, which may 
have had an effect on hyperfibrinolysis as well. Addi-
tionally, no ROTEM analysis is available after weaning 
of the drug, so no conclusion can be drawn regarding 
the time frame of hyperfibrinolysis and the need for 
continued tranexamic acid supplementation in dogs 
with hyperfibrinolysis. The human European trauma 
guidelines recommend early (< 3h after injury) treat-
ment with tranexamic acid until bleeding diminishes. 
ATC is further characterized by hypocoagulation, 
which was identified in our dog as well. Decreased MCF, 
prolonged CT and prolonged CFT were identified in the 
first ExTEM. Since the dog received fluid therapy prior 
to blood sampling for ROTEM analysis at presentation, 
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